(Q33637807)

English

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

1 reference

Europe PubMed Central

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andreas Fritsche

2

object named as

A Fritsche

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

P D Home

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

S Schinzel

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

M Massi-Benedetti

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

772-779

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01232.X

21 January 2018

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01232.X

21 January 2018

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01232.X

21 January 2018

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2010.01232.X

21 January 2018

Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellit

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CLINTHERA.2007.08.020

Identifiers

10.1111/J.1463-1326.2010.01232.X

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33637807&oldid=1996034521"